This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Apple on Wednesday announced a new longitudinal research study that will investigate relationships between different aspects of health that can be measured using its devices, potentially informing the development of new health features. Called simply the Apple Health Study, the project is a collaboration with researchers at Brigham and Women’s Hospital and will enroll volunteers through Apple’s Research app, who will share as much or as little of their health data as they like.
The nutraceutical market is expanding rapidly, valued at $6.11 billion in 2024 and projected to reach $11.55 billion by 2030, according to a GlobeNewsWire report. However, pharma companies eager to tap into this growth, face a complex road ahead. Regulatory ambiguity, for instance, serves as a double-edged sword. On the one hand, relatively less regulatory control eases market entry; on the other, they expose pharma players to intense competition from both established FMCG brands and agile start
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem. In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. But Isomorphic’s initial focus is on small-molecule drug discovery, with protein-based drugs remaining a distant twinkle in the company’s eye.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Omar Abudayyeh, Jonathan Gootenberg, and Patrick Hsu know the pains of starting biotech companies firsthand. The trio crossed paths a decade ago in CRISPR pioneer Feng Zhang ’s lab before going on to found organizations like the Arc Institute , Stylus Medicine, and Tome Biosciences. Over the years, they’ve commiserated about their respective struggles making the best RNA molecules in-house or facing lengthy wait times when ordering raw materials.
NHS England (NHSE) and the government must publish its economic review of community pharmacy for the sake of transparency in contract negotiations, the two independent pharmacy organisations have demanded. The review, promised as part of the 2022-24 pharmacy contract, aims to find out the 'full economic costs of delivering NHS pharmaceutical services' and whether NHS […] The post Economic review of pharmacy must be published now, urge IPA and NPA appeared first on The Pharmacist.
NHS England (NHSE) and the government must publish its economic review of community pharmacy for the sake of transparency in contract negotiations, the two independent pharmacy organisations have demanded. The review, promised as part of the 2022-24 pharmacy contract, aims to find out the 'full economic costs of delivering NHS pharmaceutical services' and whether NHS […] The post Economic review of pharmacy must be published now, urge IPA and NPA appeared first on The Pharmacist.
Accelerating Generic Drug Development: Strategies for Success As a pharmaceutical professional, you know how crucial it is to navigate the complex landscape of generic drug development. With the increasing demand for affordable medications, generic drug manufacturers are under pressure to expedite their development timelines without compromising on quality.
A new faculty to support pharmacists and pharmacy technicians working in or with care homes has been launched, with an introductory webinar to be held this evening. The National Care Home Faculty (NCHF) is open to any pharmacist or pharmacy technician with an interest in care home pharmacy and medicines use in care homes […] The post Faculty to support care home pharmacists launched appeared first on The Pharmacist.
As healthcare shifts toward value-based care, medication reconciliation has become a critical focus for reducing costs and improving patient outcomes. Discrepancies in medication regimens, particularly during care transitions like hospital discharge, are a leading cause of adverse drug events (ADEs). These preventable issues result in significant financial burdens on healthcare systems while compromising patient safety and care quality.
Work on the negotiations and implementation of the 2024/25 and 2025/26 community pharmacy contractual framework (CPCF) could go on until the summer, a Community Pharmacy England (CPE) subcommittee 'workplan' has suggested. The agenda for CPE's services development committee set out an April - July timeframe to 'conclude and implement 2024/25 and 2025/26 negotiations and evaluate […] The post Contract negotiations and implementation could go on until July, CPE suggests appeared first on The
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Glenmark Pharmaceuticals,USA (Glenmark), has launched Clindamycin Phosphate Foam, 1 per cent. The product is bioequivalent and therapeutically equivalent to Mylan Pharmaceuticals Inc.’s reference listed drug, Evoclin Foam, 1 per cent. According to IQVIA sales data for the 12-month period ending December 2024, the market for Evoclin Foam, 1 per cent achieved annual sales of approximately $5.8 million.
The Royal Pharmaceutical Society (RPS) has proposed formal changes to its royal charter that would allow it to become a royal college and a registered charity. RPS members will be able to vote on the proposed changes via a 'special resolution vote' (SRV) between 13 and 24 March 2025. To vote, pharmacists must be a […] The post RPS proposes formal changes to become a Royal College appeared first on The Pharmacist.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed to establish a conclusive benefit.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology sat down with Jean Redmond, Chief Operating Officer at Biologit, to discuss the use of artificial intelligence in pharmaceutical research and development and the role women play in this fast-developing area.
Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, potentially, more common obesity-related conditions.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant? In their latest study published in the journal Nature, researchers from the University of Basel challenge the conventional view that a small subset of particularly resilient bacteria are responsible for the failure of antibiotic therapies.
Policies to contain health care costs by restricting access to medicines always come with the promise of making health care more affordable and reducing government spending. But what if they’re actually doing the opposite? A new study published in JAMA on Medicaid prescription denials exposes a harsh reality: denying access to medications doesn’t save Medicaid money, it’s shifting costs in a way that hurts both patients and taxpayers.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
260 
Let's personalize your content